ASO Author Reflections: Chemotherapy Regimen in Borderline Resectable and Locally Advanced Pancreatic Cancer—Resection Cuts the Deal

por Eshmuminov, Dilmurodjon, Aminjonov, Botirjon, Palm, Russell F., Lehmann, Kuno
Publicado 2023

Using the revised Edmonton symptom assessment scale during neoadjuvant radiotherapy for retroperitoneal sarcoma

por Palm, Russell F., Jim, Heather S.L., Boulware, David, Johnstone, Peter A.S., Naghavi, Arash O.
Publicado 2020

Assessment of MRI-Linac Economics under the RO-APM

por Palm, Russell F., Eicher, Kurt G., Sim, Austin J., Peneguy, Susan, Rosenberg, Stephen A., Wasserman, Stuart, Johnstone, Peter A. S.
Publicado 2021

Effect of Favorable Pathologic Response After Neoadjuvant Radiation Therapy Alone in Soft-tissue Sarcoma

por Palm, Russell F., Liveringhouse, Casey L., Gonzalez, Ricardo J., Bui, Marilyn M., Binitie, Odion, Yang, George Q., Naghavi, Arash O.
Publicado 2022

MR-guided stereotactic body radiation therapy for intracardiac and pericardial metastases

por Sim, Austin J., Palm, Russell F., DeLozier, Kirby B., Feygelman, Vladimir, Latifi, Kujtim, Redler, Gage, Washington, Iman R., Wuthrick, Evan J., Rosenberg, Stephen A.
Publicado 2020

Surgical and Pathologic Outcomes of Pancreatic Adenocarcinoma (PA) After Preoperative Ablative Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy (A-SMART)

por Bryant, J.M., Palm, Russell F., Liveringhouse, Casey, Boyer, Emanuel, Hodul, Pam, Malafa, Mokenge, Denbo, Jason, Kim, Dae, Carballido, Estrella, Fleming, Jason B., Hoffe, Sarah, Frakes, Jessica
Publicado 2022

Induction Fluorouracil-Based Chemotherapy and PET-Adapted Consolidation Chemoradiation with Esophagectomy for High-Risk Gastroesophageal Adenocarcinoma

por Sinnamon, Andrew J., Mehta, Rutika, Saeed, Samir, Lauwers, Gregory Y., Palm, Russell F., Frakes, Jessica M., Hoffe, Sarah E., Baldonado, Jobelle J., Fontaine, Jacques P., Pimiento, Jose M.
Publicado 2023

Ablative 5-Fraction Stereotactic MRI-Guided Adaptive Radiotherapy for Oligometastatic Pancreatic Adenocarcinoma

por Webking, Samantha, Sandoval, Maria L., Chuong, Michael D., Ucar, Antonio, Aparo, Santiago, De Zarraga, Fernando, Sahin, Ibrahim, Biachi, Tiago, Kim, Dae W., Hoffe, Sarah E., Frakes, Jessica M., Palm, Russell F.
Publicado 2023

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided...

por Bryant, JM, Palm, Russell F, Herrera, Roberto, Rubens, Muni, Hoffe, Sarah E, Kim, Dae Won, Kaiser, Adeel, Ucar, Antonio, Fleming, Jason, De Zarraga, Fernando, Hodul, Pamela, Aparo, Santiago, Asbun, Horacio, Malafa, Mokenge, Jimenez, Ramon, Denbo, Jason, Frakes, Jessica M, Chuong, Michael D.
Publicado 2023

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Re...

por Eshmuminov, Dilmurodjon, Aminjonov, Botirjon, Palm, Russell F., Malleo, Giuseppe, Schmocker, Ryan K., Abdallah, Raëf, Yoo, Changhoon, Shaib, Walid L., Schneider, Marcel André, Rangelova, Elena, Choi, Yoo Jin, Kim, Hongbeom, Rose, J. Bart, Patel, Sameer, Wilson, Gregory C., Maloney, Sarah, Timmermann, Lea, Sahora, Klaus, Rössler, Fabian, Lopez-Lopez, Víctor, Boyer, Emanuel, Maggino, Laura, Malinka, Thomas, Park, Jeong Youp, Katz, Matthew H. G., Prakash, Laura, Ahmad, Syed A., Helton, Scott, Jang, Jin-Young, Hoffe, Sarah E., Salvia, Roberto, Taieb, Julien, He, Jin, Clavien, Pierre-Alain, Held, Ulrike, Lehmann, Kuno
Publicado 2023